Abacus Life, Inc. (ABL) closed the last trading session at $6.23, gaining 17.1% over the past four weeks, but there could be ...

The companies have yet to disclose how many programs they plan to collaborate on or what indications they will prioritize.

South Korea’s newest billionaire is Lee Sang-hoon, founder of ABL Bio, after it struck a $2.6 billion licensing and joint ...

Abacus Life ( ($ABL) ) just unveiled an update. On November 25, 2025, Abacus Global Management announced the timing of its inaugural annual cash ...

South Korean clinical-stage biotech ABL Bio has entered license, research and collaboration agreement with US pharma major ...

Eli Lilly invests 22 billion won in ABL Bio to fund Grabody research Lilly to receive 175,079 ABL Bio shares as part of strategic R&D partnership ...

ORLANDO, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (Nasdaq: ABL), a ...